Praxis Precision Medicines, Inc. announced the appointment of Jeffrey B. Kindler and Stuart Arbuckle to its board of directors, along with promotions for Megan Sniecinski to Chief Operating Officer and Dr. Steven Petrou to President of Research & Development. Kindler, former CEO of Pfizer, brings expertise in strategic decision-making, while Arbuckle, from Vertex Pharmaceuticals, has experience in global commercial success. The appointments aim to optimize Praxis’ value creation pathways. Sniecinski and Petrou have been instrumental in Praxis’s progress. Sniecinski’s promotion to COO will focus on growth strategy, and Petrou’s promotion reflects the company’s transition to late-stage development.

Read more at GlobeNewswire: Praxis Precision Medicines Further Positioned for